Steven De Maat

Title: Steven De Maat: Innovator in Thrombolysis Treatment

Introduction

Steven De Maat is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of medical science, particularly in the area of thrombolysis treatment. With a total of 2 patents to his name, his work focuses on innovative solutions for complex medical conditions.

Latest Patents

De Maat's latest patents include groundbreaking inventions such as "Fusion Protein for Targeted Thrombolysis for Treatment of Microvascular Thrombosis" and "Modified Serpins for the Treatment of Bradykinin-Mediated Disease." The latter invention relates to modified serine protease inhibitors (serpins) that have mutations in their reactive center loop. These modifications enhance the serpin's ability to inhibit plasma kallikrein while ensuring minimal inhibition of thrombin and activated protein C. The invention also includes nucleic acid molecules encoding these modified serpins, which can be utilized in gene therapy vectors and pharmaceutical compositions.

Career Highlights

Throughout his career, Steven De Maat has worked with various organizations, including Preclinics Gesellschaft für Präklinische Forschung GmbH and UMC Utrecht Holding B.V. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

One of his notable collaborators is Coen Maas. Their partnership has likely fostered a productive environment for research and development in their respective fields.

Conclusion

Steven De Maat's contributions to medical science through his patents and collaborations highlight his role as an innovator in thrombolysis treatment. His work continues to pave the way for advancements in the treatment of complex medical conditions.